Evidence map›Paper›PMID 29110027›Full record

ArticleInternational journal of public health2018

Human papillomavirus vaccine uptake in adolescence and adherence to cervical cancer screening in Switzerland: a national cross-sectional survey.

Monica N Wymann, Anne Spaar Zographos, Ekkehardt Altpeter, Virginie Masserey Spicher, Nicola Low, Mirjam Mäusezahl-Feuz

Open access · hybridAbstract read
In one paragraph

Article in International journal of public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Monica N WymannCommunicable Disease Division, Swiss Federal Office of Public Health, Schwarzenburgstrasse 157, 3003, Bern, Switzerland. monica.wymann@bag.admin.ch.
Anne Spaar ZographosCommunicable Disease Division, Swiss Federal Office of Public Health, Schwarzenburgstrasse 157, 3003, Bern, Switzerland.
Ekkehardt AltpeterCommunicable Disease Division, Swiss Federal Office of Public Health, Schwarzenburgstrasse 157, 3003, Bern, Switzerland.
Virginie Masserey SpicherCommunicable Disease Division, Swiss Federal Office of Public Health, Schwarzenburgstrasse 157, 3003, Bern, Switzerland.
Nicola LowInstitute of Social and Preventive Medicine, University of Bern, Finkenhubelweg 11, 3012, Bern, Switzerland.
Mirjam Mäusezahl-FeuzCommunicable Disease Division, Swiss Federal Office of Public Health, Schwarzenburgstrasse 157, 3003, Bern, Switzerland.
Federal Office of Public Health · CHInstitute of Social and Preventive Medicine · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe objectives were to measure uptake of and factors associated with human papillomavirus (HPV) vaccination initiation and to determine whether HPV vaccination reduced the uptake of cervical cancer screening.

methodsWe conducted a cross-sectional survey in a random sample of Swiss women aged 18-49 years in 2014 (N = 3588).

resultsVaccination initiation was 69.3% and full coverage (three doses) 54.1% for 18-20-year olds, respectively, 42.4% and 33.9% for 21-24-year olds. Women with ≥ 10 lifetime sexual partners were less likely to have received any HPV vaccination than women with ≤ 2 partners (18-20 years OR 0.2, 21-24 years OR 0.5). Amongst 1000 unvaccinated women (18-24 years), reasons for not having initiated vaccination were lack of information (22.5%) and fear of vaccine side effects (18.1%). Vaccination status was not associated with adherence to cervical cancer screening recommendations (OR 1.3). 95.4% of all vaccinated participants knew about the continued need for screening.

conclusionsOur data suggest that HPV vaccination is not associated with reduced uptake of cervical cancer screening. This study provides information that can be used to improve HPV vaccination uptake in Switzerland.

Indexed as

AdolescentAdultCross-Sectional StudiesEarly Detection of CancerFemaleHealth Care SurveysHumansMiddle AgedPapillomavirus VaccinesPatient ComplianceSwitzerlandUterine Cervical NeoplasmsVaccinationYoung AdultPapillomavirus VaccinesCervical cancer screeningDeterminantsHPV vaccinationSexual behaviorVaccine hesitancy

Identifiers

PMID29110027
PMCPMC5766720
OpenAlexW2767699816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.